Global CAR T-Cell Therapy Market Worth US$ 18.1 Bn by 2033

DELHI, India - June 13, 2025 - PRLog -- Global CAR T-Cell Therapy Market Size and Trends

The global chimeric antigen receptor (CAR) T-cell therapy market size was valued at USD 4.6 billion in 2024 and is projected to hit around USD 18.1 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025 to 2033.

Global CAR T-Cell Therapy Market Growth Drivers

Several factors contribute to the expansion of the global CAR T-cell therapy market. First and foremost, rising incidences of cancer have catalyzed the demand for effective treatment solutions. According to numerous studies, cancer rates are expected to escalate, prompting healthcare systems to explore and invest in advanced therapeutic options like CAR T-cell therapy.

In addition, the growing acceptance of personalized medicine has fostered an environment ripe for market growth. As more patients seek treatments tailored to their unique genetic profiles, CAR T-cell therapies have emerged as a favorable choice due to their personalization capabilities. Furthermore, ongoing clinical trials and research initiatives continue to demonstrate the effectiveness and versatility of CAR T-cell therapies, attracting significant investment from pharmaceutical companies.

This report presents an in-depth assessment of the global CAR T-cell therapy market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global CAR T-cell therapy market. The report also provides up-to-date historical market size data for the period 2021 – 2024 and an illustrative forecast to 2033 covering key market aspects like market value, share, analysis, and trends for the global CAR T-cell therapy market.

Get Free Sample Report: https://dpiresearch.com/report/global-car-t-cell-therapy-...